NEPHROS, INC. Income (Loss) from Continuing Operations, Per Diluted Share
NEPHROS, INC. (NEPH) reported Income (Loss) from Continuing Operations, Per Diluted Share of $340085.00 per share for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2026-05-07
- NEPHROS, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2026-03-31 was $340085.00, a 2106.05% increase year-over-year.
- NEPHROS, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2025-09-30 was $428913.00, a 1066.57% increase year-over-year.
- NEPHROS, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2025-06-30 was $212619.00.
- NEPHROS, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2025-03-31 was $15416.00.
- NEPHROS, INC. income (loss) from continuing operations, per diluted share for fiscal 2025 was $355775.00, a 363.21% increase from fiscal 2024.
- NEPHROS, INC. income (loss) from continuing operations, per diluted share for fiscal 2024 was $76807.00.
- NEPHROS, INC. income (loss) from continuing operations, per diluted share for fiscal 2023 was -$0.15.
- NEPHROS, INC. income (loss) from continuing operations, per diluted share for fiscal 2022 was -$0.42.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Diluted Share 9 month | Income (Loss) from Continuing Operations, Per Diluted Share 12 month |
|---|---|---|---|---|
| 2026-03-31 | $340085.00 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | $355775.00 10-K · filed 2026-03-12 | |||
| 2025-09-30 | $428913.00 10-Q · filed 2025-11-06 | $242177.00 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | $212619.00 10-Q · filed 2025-08-07 | $91502.00 10-Q · filed 2025-08-07 | ||
| 2025-03-31 | $15416.00 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | $76807.00 10-K · filed 2026-03-12 | |||
| 2024-09-30 | $36767.00 10-Q · filed 2025-11-06 | |||
| 2023-12-31 | -$0.15 10-K · filed 2024-03-15 | |||
| 2023-09-30 | -$0.02 10-Q · filed 2023-11-08 | -$0.09 10-Q · filed 2023-11-08 | ||
| 2023-06-30 | -$0.04 10-Q · filed 2023-08-09 | -$0.07 10-Q · filed 2023-08-09 | ||
| 2022-12-31 | -$0.42 10-K · filed 2024-03-15 | |||
| 2022-09-30 | -$0.12 10-Q · filed 2023-11-08 | -$0.35 10-Q · filed 2023-11-08 | ||
| 2022-06-30 | -$0.07 10-Q · filed 2023-08-09 | -$0.22 10-Q · filed 2023-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |